Clinical trial
A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00303576 · International Partnership for Microbicides, Inc., Industry · Completed
Key facts
| NCT number | NCT00303576 |
|---|---|
| Title | A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel |
| Official title | A Phase I/II Double-Blind, Randomized Study of the Safety, Tolerability and Systemic Absorption of TMC120 Vaginal Microbicide Gel and Matching Placebo in Healthy HIV-Negative Women. |
| Lead sponsor | International Partnership for Microbicides, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | dapivirine (TMC120) vaginal gel |
| Enrollment | 112 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Mar 17, 2006 |
| Last update posted | Jul 31, 2006 |
| Countries | Rwanda, South Africa, Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: